CEO compensation packages with high remuneration are not uncommon in the Biopharmaceutical industry. However, a significant number of top executives received substantial pay hikes last year, indicating that it is currently a favorable time to be a CEO in Biopharmaceuticals.
It’s worth noting that high compensation packages for chief executives are not exclusive to the Biopharmaceuticals industry. In fact, CEO salaries in other sectors often far exceed those in biopharmaceuticals. As an example, Sundar Pichai of Alphabet (GOOG) held the top spot with a salary of $225 million last year, while the highest-paid CEO in pharma (Doug Ingram of Sarepta Therapeutics, Inc.) earned $124 million.
The CEOWORLD magazine Executive Council collected data on more than 320 CEO compensation packages covering pharmaceutical, biotechnology, and life science companies. Three brought in paydays over $50 million, and one CEO broke the $100 million mark.
Top-Paid Biopharmaceutical CEOs in the United States
| Rank | CEO | Company | CEO Pay |
|---|---|---|---|
| 1 | Doug Ingram | Sarepta Therapeutics, Inc. (SRPT) | $124,938,694 |
| 2 | Pablo Legorreta | Royalty Pharma | $93,478,402 |
| 3 | David R. Epstein | Seagen Inc. (SGEN) | $57,460,546 |
| 4 | Kimberly Blackwell | Zentalis Pharmaceuticals, Inc. (ZNTL) | $36,614,376 |
| 5 | Albert Bourla | Pfizer (PFE) | $33,017,453 |
| 6 | Clay Siegall | Seagen Inc. (SGEN) | $32,758,022 |
| 7 | Anne Wojcicki | 23andMe | $32,546,430 |
| 8 | Chris Viehbacher | Biogen | $30,488,593 |
| 9 | Ari Bousbib | IQVIA | $30,135,029 |
| 10 | Marc Casper | Thermo Fisher Scientific | $28,208,909 |
| 11 | Francis deSouza | Illumina | $26,752,197 |
| 12 | Michel Vounatsos | Biogen | $26,625,221 |
| 13 | Richard Gonzalez | AbbVie | $26,287,185 |
| 14 | Daniel Faga | AnaptysBio | $24,440,350 |
| 15 | Daniel O’Day | Gilead Sciences | $21,621,253 |
| 16 | Robert Ford | Abbott Laboratories | $21,452,566 |
| 17 | Bob Bradway | Amgen | $21,399,733 |
| 18 | David Ricks | Eli Lilly | $21,398,135 |
| 19 | Samarth Kulkarni | CRISPR Therapeutics | $20,734,359 |
| 20 | Samantha Du | Zai Lab | $20,212,141 |
| 21 | Giovanni Caforio | Bristol Myers Squibb | $20,053,032 |
| 22 | Stéphane Bancel | Moderna | $19,363,648 |
| 23 | Kevin Lobo | Stryker Corporation | $18,563,214 |
Have you read?
Best Fashion Schools In The World.
Best Business Schools In The World.
Best CEOs And C-Suite Executives In The World.
World’s Most Influential and Innovative Companies.
World’s Best Hospitality And Hotel Management Schools.
Ready to join the CEOWORLD magazine Executive Council– Find out if you are eligible to apply.
Add CEOWORLD magazine to your Google News feed.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
This report/news/ranking/statistics has been prepared only for general guidance on matters of interest and does not constitute professional advice. You should not act upon the information contained in this publication without obtaining specific professional advice. No representation or warranty (express or implied) is given as to the accuracy or completeness of the information contained in this publication, and, to the extent permitted by law, CEOWORLD magazine does not accept or assume any liability, responsibility or duty of care for any consequences of you or anyone else acting, or refraining to act, in reliance on the information contained in this publication or for any decision based on it.
Copyright 2024 The CEOWORLD magazine. All rights reserved. This material (and any extract from it) must not be copied, redistributed or placed on any website, without CEOWORLD magazine' prior written consent. For media queries, please contact: info@ceoworld.biz
SUBSCRIBE NEWSLETTER
